✨
AI Summary
- Medicare spending projections for Alzheimer's treatment Leqembi are discussed.
- Janet Woodcock's new role post-FDA and focus on rare diseases is highlighted.
- Preparations for new pneumococcal vaccines entering the market are reviewed.